Back to search

Article

In Vivo CRISPR Gene Editing in Patients with Herpes Stromal Keratitis

2023-02-24

Abstract excerpt

In vivo CRISPR gene therapy holds large clinical potential, but the safety and efficacy remain largely unknown. Here, we injected a single dose of HSV-1-targeting CRISPR formulation in the cornea of three patients with severe refractory herpes stromal keratitis (HSK) during corneal transplantation. Our study is an investigated initiated, open-label, single-arm, non-randomized interventional trial at a single cente...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0592ed38-2988-59b2-8350-ada07d90198f
DOI
10.1101/2023.02.21.23285822
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In Vivo CRISPR Gene Editing in Patients with Herpes Stromal KeratitisDOI 10.1101/2023.02.21.23285822
Select a neighboring publication to make it the new centre.